Price Alert

Kindred Biosciences Inc. (KIN)

NASDAQ: KIN · Real-Time Price · USD

9.25

0.01 (0.11%)

At close: Apr 24, 2025, 3:47 PM

Kindred Biosciences Statistics

Share Statistics

Kindred Biosciences has 0 shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 921.21K, so 0% of the outstanding shares have been sold short.

Short Interest	921.21K
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.25

Valuation Ratios

The PE ratio is -7.17 and the forward PE ratio is null. Kindred Biosciences's PEG ratio is 0.12.

PE Ratio	-7.17
Forward PE	n/a
PS Ratio	4.02
Forward PS	n/a
PB Ratio	2.51
P/FCF Ratio	-12.55
PEG Ratio	0.12

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Kindred Biosciences.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.08, with a Debt / Equity ratio of 0.3.

Current Ratio	9.08
Quick Ratio	9.05
Debt / Equity	0.3
Debt / EBITDA	-1.34
Debt / FCF	-1.51
Interest Coverage	-10.92

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$669.27K
Profits Per Employee	$-374.98K
Employee Count	63
Asset Turnover	0.44
Inventory Turnover	22.35

Taxes

Income Tax	1.83M
Effective Tax Rate	-8.39%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.32, so Kindred Biosciences's price volatility has been higher than the market average.

Beta	1.32
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	1,505,521

Income Statement

In the last 12 months, Kindred Biosciences had revenue of 42.16M and earned -23.62M in profits. Earnings per share was -0.6.

Revenue	42.16M
Gross Profit	37.54M
Operating Income	-19.97M
Net Income	-23.62M
EBITDA	-15.29M
EBIT	-19.97M
Earnings Per Share (EPS)	-0.6

Full Income Statement

Balance Sheet

The company has 11.62M in cash and 20.44M in debt, giving a net cash position of -8.82M.

Cash & Cash Equivalents	11.62M
Total Debt	20.44M
Net Cash	-8.82M
Retained Earnings	-244.85M
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.86M and capital expenditures -3.64M, giving a free cash flow of -13.49M.

Operating Cash Flow	-9.86M
Capital Expenditures	-3.64M
Free Cash Flow	-13.49M
FCF Per Share	-0.34

Full Cash Flow Statement

Margins

Gross margin is 89.03%, with operating and profit margins of -47.36% and -56.03%.

Gross Margin	89.03%
Operating Margin	-47.36%
Pretax Margin	-51.69%
Profit Margin	-56.03%
EBITDA Margin	-36.27%
EBIT Margin	-47.36%
FCF Margin	-32.01%

Dividends & Yields

KIN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for KIN.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a